Skip to main content

Advertisement

SpringerLink
Log in

Bisphosphonates and osteoporosis

  • Session XI: Treatment: Fluoride, Bisphosphonates, Anabolic Steroids And New Developments
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fleisch H, Russel RGG, Francis MD. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue cultures in vivo. Science 1969;165:1262–4.

    Google Scholar 

  2. Boonenkamp PM, Wee-Pals LJA vd, Wijk-v Lennep MML v, Thesing CW, Bijvoet OLM. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix. Bone Miner 1986;1:27–39.

    Google Scholar 

  3. Mühlbauer RL, Bauss F, Schenk R, Janner M, Bosies E, Strein K, et al. BM21.0955, a potent new bisphosphonate to inhibit bone resorption. J Bone Miner Res 1991;6:1003–11.

    Google Scholar 

  4. Minaire P, Berard E, Meunier PJ, Edouvard C, Goedert G, Pilonchery G. effects of disodium dicholoromethylene diphosphonate on bone loss in paraplegic patients. Clin Invest 1981;68:1086–92.

    Google Scholar 

  5. Reid IR, King AR, Alexander CJ, Ibbertson HK. Preve-ntion of steroid-induced osteoporosis with (3-ami-nolhydroxypyrolidine) l,lbisphosphonate (APD). Lancet 1988;1:143–6.

    Google Scholar 

  6. Smith ML, Fogelman I, Hart DM, et al. Effect of etidronate disodium on bone turnover following surgical menopause. Calcif Tissue Int. 1989;44:74–9.

    Google Scholar 

  7. Reginster JV, Deroisy R, Denis D, Collette J, Lecart MP, Sarlet N, et al. Prevention of postmenopausal bone loss by tiludronate. Lancet 1989;2:1469–71.

    Google Scholar 

  8. Jowsey J, Riggs BL, Kelly PJ, Hoffman DL, Bordier PJ. The treatment of osteoporosis with disodium ethane-1-hydroxy-1,1-diphosphonate. Lab Clin Med 1971;78:574–84.

    Google Scholar 

  9. Valkema R, Vismans F-JFE, Papapoulos SE, Pauwels EKJ, Bijvoet OLM. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD. Bone Miner 1989;5:183–92.

    Google Scholar 

  10. Anderson C, Cape RDT, Crilly RG, Hodsman AB, Wolfe BMJ Preliminary observations of a form of coherence therapy for osteoporosis. Calcif Tissue Int 1984;36:341–3.

    Google Scholar 

  11. Miller PD, Neal BJ, McIntyre DO, Yanover MJ, Anger MS, Kowalski LJ. The effect of coherence (ADFR) therapy with phosphate and etidronate on axial bone mineral density in postmenopausal osteoporosis: a prospective longitudinal study. Bone Miner Res 1989;4:S193.

    Google Scholar 

  12. Hodsman AB. Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric study. Bone Miner 1989;5:201–12.

    Google Scholar 

  13. Steiniche T, Hasling C, Charles P, Eriksen EF, Melsen F, Mosekilde L. The effect of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: a randomized study comparing intermittent treatment with an ADFR regime. Bone 1991;12:155–63.

    Google Scholar 

  14. Hesch RD, Heck J, Delling G, et al. Results of a stimulatory therapy of low bone metabolism in osteoporosis with (138) hPTH and diphosphonate EHDP. Klin Wochenschr 1988;66:976–84.

    Google Scholar 

  15. Devogelaer JP, Nagant de Deuxchaisnes C. Treatment of involutional osteoporosis with bisphosphonate (APD) (disodium Pamidronate): Non-linear increase of lumbar bone mineral density. In: Christiansen C, Overgaard K, editors. Osteoporosis 1990. Aalborg: Osteopress, 1990:1507–9.

    Google Scholar 

  16. Chestnut CH. Synthetic salmon calcitonin, diphosphonates and anabolic steroids in the treatment of postmenopausal osteoporosis Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL, editors. Osteoporosis 1985. Aalborg: Osteopress, 1985:549–55.

    Google Scholar 

  17. Mallette LE, LeBIanc AD, Pool JL, Mechanik JI. Cyclic therapy of osteoporosis with neutral phosphate and brief, High-dose pulses of etidronate. J Bone Miner Res 1989;4:143–8.

    Google Scholar 

  18. Storm T, Thamsborg G, Steiniche T, Genant HK, Sørensen OH. Effect of intermittent cyclical etidronate therapy in bone mass and fracture rate in women with postmenopausal osteoporosis. N Engl J Med 1990;323:1265–71.

    Google Scholar 

  19. Watts NB, Harris ST, Genant HK et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 1990;323:739

    Google Scholar 

  20. Pacifici R, McMurtry C, Vered I, Rupich R, Avioli LV. Coherence therapy does not prevent axial bone loss in osteoporotic women: apreliminary comparative study. J Clin Endocrinol Metab 1988:66:747–53.

    Google Scholar 

  21. Ott SM, Woodson GC, Hoffer W. Bone histomorphometric changes in women with postmenopausal osteoporosis treated with etidronate. In: Christiansen C, Overgaard K, editors. Osteoporosis 1990. Aalborg: Osteopress, 1990. 1318–22.

    Google Scholar 

  22. Barbier A, Bonjour JP, Geusens P, De Vernejoul MC, Lacheretz F, Tiludronate: a bisphosphonate with a positive effect on bone quality in experimental models. J Bone Miner Res 1991;6:S217.

    Google Scholar 

  23. Toolan BC, Shea M, Myers ER, et al. The effect of long-term alendronate treatment on vertebrae strength in ovariectomized rats and baboons. J Bone Miner Res;6:S248.

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Sundby Hospital, Copenhagen, Denmark

    O. Helmer Sørensen, T. Storm, G. Thamsborg, H. Ancher Sørensen & G. Kollerup

  2. Aarhus Amtssygehus, University Institute of Pathology, Denmark

    T. Steiniche & F. Melsen

  3. Department of Radiology, Medicine and Orthopedic Surgery, University of California, San Francisco, California, USA

    H. K. Genant

Authors
  1. O. Helmer Sørensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Storm
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Thamsborg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Ancher Sørensen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. Kollerup
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. T. Steiniche
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Melsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H. K. Genant
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sørensen, O.H., Storm, T., Thamsborg, G. et al. Bisphosphonates and osteoporosis. Osteoporosis Int 3 (Suppl 1), 223–225 (1993). https://doi.org/10.1007/BF01621913

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01621913

Keywords

Search

Navigation